Academic Profile

Dr. Tan is an interdisciplinary cognitive neuroscientist whose research interest lies broadly in using neuroimaging techniques (MRI, PET, DOT), genetics, and psychosocial factors to understand the earliest risk markers of neurodegenerative diseases and cognitive decline. Dr. Tan's research in the cognitive neuroscience and genetics of aging and dementia has been published in high impact journals such as Acta Neuropathologica, Brain, and Annals of Neurology.

Dr. Tan received his PhD in Psychology (Cognitive Neuroscience) from the University of Illinois and his BSocSci with First Class Honours from NUS. Before joining NTU, he was a Postdoctoral Scholar in the Neuroradiology Section of the Department of Radiology and Biomedical Imaging at the University of California, San Francisco (UCSF).
chinhong.tan_1_2.JPG picture
Asst Prof Tan Chin Hong
Assistant Professor, School of Social Sciences

Cognitive neuroscience of ageing, Cerebrovascular disease, Alzheimer's polygenic risk, Human neuroimaging, Diffuse optical tomography, Cardiorespiratory fitness, Cognitive decline and progression to clinical dementia.
  • Advancing the definition of cognitive frailty: the association of combined prefrailty and subjective memory complaints (“Cognitive-Prefrailty”) with cognitive performance, physical function and quality of life in community-dwelling older adults

  • Associations of amyloid deposition with a magnetic resonanceimaging (MRI) measure of cerebrovascular and degenerative pathology in individuals with mild cognitive impairment

  • Prevention of and Biomarkers for Vascular Cognitive Impairment

  • Socioeconomic Status and Cognitive Impairment: The Mediating Effects of Cardiovascular Function and Brain Volume
  • Tan CH, Hilal S, Xu X, Vrooman H, Cheng CY, Wong TY, Venketaubramanian N, Chen C. (2020). MRI markers of mixed pathology and cognitive impairment in multiethnic Asians. Journal of Alzheimer's Disease, 73(4), 1501-1509.

  • Tan CH, Low KA, Chiarelli AM, Fletcher MA, Navarra R, Burzynska AZ, Kong TS, Zimmerman B, Maclin EL, Sutton BP, Gratton G, Fabiani M. (2019). Optical Measures of Cerebral Arterial Stiffness are Associated with White Matter Signal Abnormalities and Cognitive Performance in Normal Aging. Neurobiology of Aging, 84, 200-207.

  • Tan CH*, Bonham LW*, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Yokoyama JS, Rabinovici GD, Miller BL, Yaffe K, Schellenberg GS, Kauppi K, Holland D, McEvoy LK, Kukull WA, Tosun D, Weiner MW, Sperling RA, Bennett DA, Hyman BT, Andreassen OA, Dale AM, Desikan RS. (2019). Polygenic Hazard Score, Amyloid Deposition and Alzheimer’s Neurodegeneration. Brain, 142(2), 460-470 [*joint-first].

  • Tan CH, Fan CC, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Dillon WP, Bonham LW, Yokoyama JS, Karch CM, Brewer JB, Rabinovici GD, Miller BL, Schellenberg GD, Kauppi K, Feldman HA, Holland D, McEvoy LK, Hyman BT, Andreassen OA, Dale AM, Desikan RS. (2018). Polygenic hazard score: an enrichment marker for Alzheimer’s associated amyloid and tau deposition. Acta Neuropathologica, 135(1), 85-93.

  • Tan CH, Hyman BT, Tan JJX, Hess CP, Dillon WP, Schellenberg GD, Besser LM, Kukull WA, Kauppi K, McEvoy LK, Andreassen OA, Dale AM, Fan CC, Desikan RS. (2017). Polygenic hazard scores in preclinical Alzheimer disease. Annals of Neurology, 82(3), 484-488.